Literature DB >> 27612962

Role of proneurotensin as marker of paediatric coeliac disease.

C Montén1, Å Torinsson Naluai2, D Agardh1.   

Abstract

Neurotensin (NT) is a gut hormone functioning proinflammatory through nuclear factor kappa B (NF-κB) and interleukin (IL)-8 secretion or anti-inflammatory through epidermal growth factor receptors. NT mRNA is down-regulated in duodenal biopsies of children with untreated coeliac disease. The aim of this study was to investigate if plasma pro-NT levels correlated with the degree of intestinal mucosal damage and tissue transglutaminase autoantibody (tTGA) levels in children with coeliac disease. Fasting plasma samples from 96 children with coeliac disease and 89 non-coeliac disease controls were analysed for NT precursor fragment pro-NT 1-117 by a chemiluminometric immunoassay. Pro-NT levels were compared with NT mRNA from duodenal biopsies, assessed previously with quantitative polymerase chain reaction (PCR). Illumina core exome arrays were used for human leucocyte antigen (HLA) typing and the Marsh criteria applied to score mucosal damage. Tissue TGA was measured by radio binding assay. A general linear model compared pro-NT levels with diagnosis of coeliac disease, Marsh score and HLA DQ haplotype. Spearman's rank test was used to compare pro-NT levels with tTGA, age and duodenal NT mRNA levels, respectively. Plasma pro-NT levels were elevated in children with coeliac disease (median 23 pmol/l higher, P = 0·003) and in those with severe intestinal mucosal damage (median 24 pmol/l higher for ≥ Marsh 3b versus not, P = 0·0004). Pro-NT levels correlated further with tTGA (r2  = 0·22, P = 0·002), but not with duodenal NTS mRNA levels (r2  = -0·12, P = 0·14). Pro-NT was not associated with any of the HLA risk-haplotypes. Elevated peripheral pro-NT levels reflect more severe forms of active coeliac disease, indicating a potential role of NT in intestinal inflammation.
© 2016 British Society for Immunology.

Entities:  

Keywords:  children; coeliac disease; inflammation; neurotensin

Mesh:

Substances:

Year:  2016        PMID: 27612962      PMCID: PMC5108069          DOI: 10.1111/cei.12864

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation.

Authors:  Dezheng Zhao; Charalabos Pothoulakis
Journal:  Peptides       Date:  2006-07-26       Impact factor: 3.750

Review 2.  The diagnostic accuracy of serologic tests for celiac disease: a systematic review.

Authors:  Alaa Rostom; Catherine Dubé; Ann Cranney; Navaaz Saloojee; Richmond Sy; Chantelle Garritty; Margaret Sampson; Li Zhang; Fatemeh Yazdi; Vasil Mamaladze; Irene Pan; Joanne MacNeil; David Mack; Dilip Patel; David Moher
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

3.  Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.

Authors:  H Barelli; J E Fox-Threlkeld; V Dive; E E Daniel; J P Vincent; F Checler
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 4.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

5.  A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

Authors:  Kristoffer L Egerod; Maja S Engelstoft; Kaare V Grunddal; Mark K Nøhr; Anna Secher; Ichiro Sakata; Jens Pedersen; Johanne A Windeløv; Ernst-Martin Füchtbauer; Jørgen Olsen; Frank Sundler; Jan P Christensen; Nils Wierup; Jesper V Olsen; Jens J Holst; Jeffrey M Zigman; Steen S Poulsen; Thue W Schwartz
Journal:  Endocrinology       Date:  2012-10-12       Impact factor: 4.736

6.  Neurotensin inhibits meal-stimulated gastric acid secretion in man.

Authors:  P Skov Olsen; J Holst Pedersen; P Kirkegaard; F Stadil; J Fahrenkrug; J Christiansen
Journal:  Scand J Gastroenterol       Date:  1983-11       Impact factor: 2.423

7.  Isolation of human intestinal neurotensin.

Authors:  R A Hammer; S E Leeman; R Carraway; R H Williams
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

8.  Validity of histology for the diagnosis of paediatric coeliac disease: a Swedish multicentre study.

Authors:  Caroline Montén; Kaj Bjelkenkrantz; Audur H Gudjonsdottir; Lars Browaldh; Henrik Arnell; Åsa Torinsson Naluai; Daniel Agardh
Journal:  Scand J Gastroenterol       Date:  2015-12-04       Impact factor: 2.423

9.  Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor.

Authors:  R E Carraway; S P Mitra; C Paradise
Journal:  Peptides       Date:  1991 May-Jun       Impact factor: 3.750

10.  Genes involved in muscle contractility and nutrient signaling pathways within celiac disease risk loci show differential mRNA expression.

Authors:  Caroline Montén; Audur H Gudjonsdottir; Lars Browaldh; Henrik Arnell; Staffan Nilsson; Daniel Agardh; Åsa Torinsson Naluai
Journal:  BMC Med Genet       Date:  2015-06-30       Impact factor: 2.103

View more
  4 in total

1.  Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation.

Authors:  Giuseppe Riezzo; Guglielmina Chimienti; Caterina Clemente; Benedetta D'Attoma; Antonella Orlando; Caterina Mammone Rinaldi; Francesco Russo
Journal:  Biomed Res Int       Date:  2017-09-07       Impact factor: 3.411

Review 2.  An Overview of Celiac Disease in Childhood Type 1 Diabetes.

Authors:  Iraj Shahramian; Ali Bazi; Alireza Sargazi
Journal:  Int J Endocrinol Metab       Date:  2018-06-27

3.  Plasma Proneurotensin and Prediction of Cause-Specific Mortality in a Middle-aged Cohort During Long-term Follow-up.

Authors:  Ayesha Fawad; Andreas Bergmann; Janin Schulte; Zahra A Butt; Peter M Nilsson; Louise Bennet; Marju Orho-Melander; Olle Melander
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

4.  Fasting Neurotensin Levels in Pediatric Celiac Disease Compared with a Control Cohort.

Authors:  Donatella Iorfida; Monica Montuori; Chiara Maria Trovato; Claudio Tiberti; Andrea Sansone; Salvatore Cucchiara; Francesco Valitutti
Journal:  Gastroenterol Res Pract       Date:  2020-02-22       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.